The use of a complex of ferric oxyhydroxide, sucrose and starch (Velforo 500) in patients on programmed hemodialysis in the routine practice of an outpatient dialysis center: results of a prospective randomized trial

Nephrology ◽  
2021 ◽  
Vol 4_2021 ◽  
pp. 22-29
Author(s):  
D.V. Artemov Artemov ◽  
Sign in / Sign up

Export Citation Format

Share Document